The research results show that m6A demethylase in tumor cells contributes to the effect of immunotherapy, and ALKBH5 is identified as a potential therapeutic target to improve the efficacy of immunotherapy for melanoma, colorectal cancer and other potential cancers (125). This evidence concerns the gene ALKBH5 and colorectal cancer.